Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tyenne. Always confirm against the full prescribing information.
100 interactions
Abrocitinib
The metabolism of Abrocitinib can be increased when combined with Tocilizumab.
Level 1 evidence
Acebutolol
The metabolism of Acebutolol can be increased when combined with Tocilizumab.
Level 1 evidence
Acetaminophen
The metabolism of Acetaminophen can be increased when combined with Tocilizumab.
Level 1 evidence
Acetylsalicylic acid
The metabolism of Acetylsalicylic acid can be increased when combined with Tocilizumab.
Level 1 evidence
Acyclovir
The metabolism of Acyclovir can be increased when combined with Tocilizumab.
Level 1 evidence
Aficamten
The metabolism of Aficamten can be increased when combined with Tocilizumab.
Level 1 evidence
Albendazole
The metabolism of Albendazole can be increased when combined with Tocilizumab.
Level 1 evidence
Alfentanil
The metabolism of Alfentanil can be increased when combined with Tocilizumab.
Level 1 evidence
Almotriptan
The metabolism of Almotriptan can be increased when combined with Tocilizumab.
Level 1 evidence
Alogliptin
The metabolism of Alogliptin can be increased when combined with Tocilizumab.
Level 1 evidence
Alosetron
The metabolism of Alosetron can be increased when combined with Tocilizumab.
Level 1 evidence
Alprazolam
The metabolism of Alprazolam can be increased when combined with Tocilizumab.
Level 1 evidence
Enter your NPI to unlock 37 major interactions for Tyenne
Tyenne (Tocilizumab-Aazg) has 858 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Tyenne (Tocilizumab-Aazg) has 265 major, 476 moderate, and 117 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tyenne. Always confirm against the full prescribing information.